People Search
Phones, Emails, Addresses, Background check, Web references
All public info
Like other search engines (Google or Bing) Radaris collects information from public sources.
Miguel has been leading and championing the cell and gene sector for decades in academic, regulatory, and industry CEO roles.
He's a multi-time biotech founder and current biotech CEO. He was once a regulator. He's a physician. He serves on multiple boards. And as of this summer, he's ...
Languages. English. Full professional proficiency. Portuguese. Native or bilingual proficiency. French. Full professional proficiency. Spanish.
Dr. Forte has significant experience in regenerative medicine and in the cell therapy industry, most recently as Chief Executive Officer.
Miguel Forte is the Chief Executive Officer of Zelluna Immunotherapy and currently Chief Commercialization Officer and Chair of the Commercialization Committee.
BioLeader interview with Miguel Forte. Miguel is CEO of Bone Therapeutics, a biotech company developing cell therapy products for bone ...
Miguel FORTE | Cited by 557 | of University of Aveiro, Aveiro (UA) | Read 16 publications | Contact Miguel FORTE.
Miguel Forte, CEO, Kiji Tx ... President and Board of Directors chair of the International Society of Cell and Gene Therapy (ISCT) from June 2024.
Linkedin
Biotecnol (Privately Held; Biotechnology industry): Secretary of the General Assembly, (2005-November 2009)
Biotecnol (Privately Hel...